Search results
Biogen sees ‘encouraging’ trends for postpartum depression drug
BioPharma Dive via Yahoo Finance· 19 hours agoThat’s encouraging, “as they are often the first to see PPD patients." Biogen also said two of the...
Sage (SAGE) Down 20% on Parkinson's Study Missing Primary Goal
Zacks via Yahoo Finance· 7 days agoData from a mid-stage study show that Sage's (SAGE) experimental oral drug failed to show a...
Vicor Corp (VICR) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges with ...
GuruFocus.com via Yahoo Finance· 24 hours agoVicor is prepared and confident of a positive outcome. Q: Can you quantify the increase in royalty revenue in the March quarter and discuss expectations for the remainder.
Sage Therapeutics (NASDAQ:SAGE) Shares Gap Down to $15.63
ETF DAILY NEWS· 6 days agoSage Therapeutics, Inc. (NASDAQ:SAGE – Get Free Report)’s share price gapped down before the market opened on Wednesday . The stock had previously closed at $15.63, but opened at $12.96. Sage ...
Sage Therapeutics (NASDAQ:SAGE) PT Lowered to $16.00 at TD Cowen
ETF DAILY NEWS· 6 days agoSage Therapeutics (NASDAQ:SAGE – Free Report) had its price objective lowered by TD Cowen from $30.00 to $16.00 in a research report report published on Thursday morning, Benzinga reports. The ...
Keep up with the Week 5 action on the lohud Boys Lacrosse Scoreboard
Lohud | The Journal News via Yahoo Sports· 2 days agoPel: Will Crotty 1G; Charlie Zabatta 17S. Pawling at Dobbs Ferry, ppd. Irvington at Edgemont North Rockland at White Plains Yonkers at Keio Tuesday Iona Prep 16, Fordham Prep ...
Wedbush Weighs in on Sage Therapeutics, Inc.’s Q1 2024 Earnings (NASDAQ:SAGE)
ETF DAILY NEWS· 5 days agoSage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) – Analysts at Wedbush reduced their Q1 2024 earnings estimates for Sage Therapeutics in a research note issued to investors on Wednesday, ...
Scotiabank Trims Sage Therapeutics (NASDAQ:SAGE) Target Price to $19.00
ETF DAILY NEWS· 4 days agoSage Therapeutics (NASDAQ:SAGE – Free Report) had its target price decreased by Scotiabank from $34.00 to $19.00 in a research note issued to investors on Thursday, Benzinga reports. Scotiabank ...